제11회 서울국제신약포럼 > Forum & Conference

본문 바로가기

fnMICE 파이낸셜뉴스 부산파이낸셜뉴스 fn투어 fn아이포커스 fn아트


지난행사목록

본문

 

 

 

 Introduction  

 

 

Domestic pharmaceutical companies have recently been continuing to do R&D (Research and Development) 

in order to develop global drugs moving away from the focus on generic drugs. 


When viewing how pharmaceutical companies develop new drugs, candidate materials should be sought and 

clinical trial phases 1 to 3 should be passed through after undergoing pre-clinical trials – animal testing.


However, development of new pharmaceuticals ceases intermittently, as drugs that have worked in the 

pre-clinical trials fail to have an effect on the human clinical trials. It is just as important how effective drugs could 

be in humans. 


If the effects of drugs can be identified at the cellular level of human tissues, costs and time for clinical trials can 

be saved. Hence, at the pre-clinical stage or before clinical trial, active researches into the effects of drugs using 

tissue chips or organoids have lately been proceeding in the global markets including Europe.



A tissue chip or organoid is a three-dimensional structure that has similar structure or functions to miniature body 

parts made from stem cells in order to ensure a minimum function. 

 


In Korea, however, tissue chips and organoids have never been applied in actual clinical trials. 

Even domestic pharmaceutical companies urgently need to introduce the platform technology for new drug 

development so as to stand as a global pharmaceutical company. 


At the upcoming 11th Seoul International New Pharmaceuticals Forum, we will find out how tissue chips and 

organoids will be applied in the clinical trials and help develop new drugs. 


Prof. Christopher Hughes from University of California, Irvine, an expert of tissue chips, will give a keynote speech. 

Prof. Koo, Bon Kyoung from IMBA, Austria and Dr. Jeong, Ga Young from GSK will give a lecture on the organoid 

field and the real applications of organoids respectively.  

 

 

 

 

Overview 

 

 

Title : The 11th Seoul International New Pharmaceuticals Forum

  

Theme : Paradigm Shift in the Development of New Drugs, Tissue Chips and Organoids

 

Date : June 20th, 2019(Thu) / 09:00 ~ 14:50

 

Venue : Park Ballroom, Conrad Hotel, Seoul(5F)

 

Host : The Financial News, Korea Research Institute of Chemical Technology

 

Supporters : Ministry of Health and Welfare, Ministry of Science and ICT, 

                        Ministry of Trade, Industry and Energy,

                        National Institute of Food and Drug Safety Evaluation,

                        Korea Pharmaceutical and Bio-Pharma Manufacturers Association, 

                        Korea Biotechnology Industry Organization,

                        Korea Research-based Pharmaceutical Industry Association


Inquiry : Seoul International New Pharmaceuticals Forum Bureau

                Tel. 02-6965-0013 / Mail. 8amwon@fnnews.com

첨부파일

서울특별시 용산구 효창원로 154, 파이낸셜뉴스빌딩 3층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnmice.com
Copyright 2017 The financial news. All rights reserved.